Congressional researchers on Trump’s marijuana stance; IN GOP blocks legalization vote; Transportation industry’s cannabis concerns; RI psilocybin
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.
If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
Protect the Public’s Trust, a nonprofit focused on government transparency, filed a Freedom of Information Act lawsuit against the U.S. Department of Health and Human Services for allegedly refusing to turn over marijuana rescheduling records, including communications with the Department of Justice and Drug Enforcement Administration.
The Congressional Research Service says in a new report that President Donald Trump’s approach to marijuana “remains to be seen” and that it is “unknown” if a pending cannabis rescheduling proposal will be finalized.
Representatives of the trucking and railroad industries expressed concerns about the impact that marijuana rescheduling could have on zero-tolerance drug testing policies in testimony before House Transportation & Infrastructure subcommittees.
Virginia Senate and House committees approved legislation to legalize marijuana sales despite a veto threat from Gov. Glenn Youngkin (R), with the Senate measure heading to a floor vote as the next step.
The Indiana House of Representatives’s Republican majority blocked a Democratic-led amendment to remove marijuana from the list of restricted Schedule I drugs under state law.
Key Hawaii House and Senate committee chairs introduced new legislation to legalize marijuana and create a comprehensive regulatory structure for not only adult-use cannabis but also the medical medical marijuana and hemp industries.
A Florida Republican senator withdrew a medical cannabis home cultivation bill shortly after filing it, saying he’ll reintroduce the measure without separate provisions to set new restrictions on certain hemp-derived cannabinoid products that were included in the initial measure.
Rhode Island representatives filed a bill to temporarily legalize possession, home grow and sharing of psilocybin. If the psychedelic is federally approved, state officials would set rules for cultivation, distribution and medical prescription.
/ FEDERAL
A Drug Enforcement Administration judge said a lawyer’s representation of a participant in pending marijuana rescheduling hearings was “suboptimal” after her name was connected to a motion seeking leave to file an interlocutory appeal without her knowledge or consent.
Rep. Angie Craig (D-MN) tweeted that she “sat down with several Minnesota hemp businesses this week to talk about how we can best support the industry while enacting commonsense regulations that boost responsible hemp operations.”
/ STATES
The Texas Senate Committee on State Affairs published a report addressing a charge to consider banning consumable hemp products and THC beverages.
Oregon regulators issued a recall of marijuana edibles that failed to disclose the presence of butter.
Maryland officials gave lawmakers an update on cannabis product inspections and enforcement.
Washington State regulators are conducting a survey of marijuana businesses and employees about “how to better support cannabis education efforts.”
U.S. Virgin Islands regulators awarded a cannabis track and trace contract to Metrc.
The New York Cannabis Advisory Board met.
The Virginia Cannabis Control Authority Board of Directors will meet on Wednesday.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
The Annapolis, Maryland City Council voted to end marijuana drug testing for most public employees.
/ INTERNATIONAL
Saint Lucia officials released a cannabis and hemp bill for public comment.
Jamaican lawmakers are criticizing government officials for what they see as slow progress in enacting legislation to regulate the cannabis industry.
/ SCIENCE & HEALTH
A review highlighted “the broad therapeutic potential of cannabinoids in neurology, with promising results in symptom management for conditions like Multiple Sclerosis and Fibromyalgia.”
A case report found that “after changing from LSD to MDMA at both high doses (150-175 mg) and repeated low doses (12.5-25 mg), the patient exhibited marked improvements in neuropathic pain that were sustained even after stopping repeated MDMA treatment.”
/ ADVOCACY, OPINION & ANALYSIS
The Australian Legalise Cannabis Party is criticizing Meta for its continued censorship of marijuana-related content.
/ BUSINESS
Curaleaf’s Select brand became the exclusive THC partner Austin City Limits Live.
Flowhub created a form where cannabis industry stakeholders can report their stories about being debanked ahead of a Senate Banking Committee on the issue.
atai Life Sciences announced positive topline results from a study of its synthetic intranasal formulation of 5-MeO-DMT benzoate in 12 patients with moderate to severe alcohol use disorder.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
